Kapidin (Lercanidipine Hydrochloride)

Kapidin (lercanidipine) is used to manage conditions within the hypertension disease family.

• Essential hypertension: reduces systolic and diastolic blood pressure, helping to prevent cardiovascular complications.
• Isolated systolic hypertension: provides effective blood pressure control in patients with elevated systolic readings.
• Hypertension in elderly patients: offers once‑daily dosing with a favorable tolerability profile.

• Lercanidipine selectively blocks L‑type calcium channels in vascular smooth‑muscle cells. By inhibiting calcium influx, it prevents contraction of arterial smooth muscle, leading to vasodilation and a decrease in peripheral vascular resistance. The resulting reduction in systemic vascular tone lowers both systolic and diastolic blood pressure without significant effect on cardiac conduction or contractility.

Kapidin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Headache: mild to moderate headache reported in many patients.
• Flushing: transient facial warmth and redness.
• Peripheral edema: swelling of ankles or lower legs.
• Dizziness: sensation of light‑headedness, especially after standing.

Serious or Rare Side Effects

• Angioedema: swelling of face, lips, tongue that may compromise airway.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Myocardial infarction: rare occurrence of heart attack.
• Hepatic dysfunction: abnormal liver enzymes indicating liver injury.

Before initiating Kapidin, several precautionary measures should be considered to ensure safe use.

• Blood pressure monitoring: check baseline and periodic readings to assess efficacy.
• Hepatic function: evaluate liver enzymes in patients with known liver disease.
• Elderly patients: start at low dose and monitor for edema.
• Concomitant CYP3A4 inhibitors: avoid or adjust dose when used with strong inhibitors.
• Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited.
• Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Kapidin can interact with other medicines, altering its antihypertensive effect or increasing adverse reactions.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise lercanidipine plasma levels.
• Other calcium channel blockers (e.g., amlodipine, nifedipine): additive vasodilatory effect can cause severe hypotension.
• Grapefruit juice: potent CYP3A4 inhibition leading to increased drug exposure.

Moderate Interactions (Monitor Closely)

• Diuretics: combined effect may enhance blood pressure reduction, requiring dose adjustment.
• Beta‑blockers: may mask tachycardia that signals hypotension.
• ACE inhibitors or ARBs: additive antihypertensive effect may necessitate closer monitoring.